318 related articles for article (PubMed ID: 26528835)
1. Pharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticles.
Kang H; Mintri S; Menon AV; Lee HY; Choi HS; Kim J
Nanoscale; 2015 Dec; 7(45):18848-62. PubMed ID: 26528835
[TBL] [Abstract][Full Text] [Related]
2. Nano-carriers for targeted delivery and biomedical imaging enhancement.
Parekh G; Shi Y; Zheng J; Zhang X; Leporatti S
Ther Deliv; 2018 May; 9(6):451-468. PubMed ID: 29722631
[TBL] [Abstract][Full Text] [Related]
3. From one to all: self-assembled theranostic nanoparticles for tumor-targeted imaging and programmed photoactive therapy.
Li X; Wang X; Zhao C; Shao L; Lu J; Tong Y; Chen L; Cui X; Sun H; Liu J; Li M; Deng X; Wu Y
J Nanobiotechnology; 2019 Feb; 17(1):23. PubMed ID: 30711005
[TBL] [Abstract][Full Text] [Related]
4. An Assessment of In-vitro and In-vivo Evaluation Methods for Theranostic Nanomaterials.
Parashar P; Singh N; Alka ; Maurya P; Saraf SA
Curr Pharm Des; 2022; 28(2):78-90. PubMed ID: 34348616
[TBL] [Abstract][Full Text] [Related]
5. Hierarchical self-assembly of magnetic nanoclusters for theranostics: Tunable size, enhanced magnetic resonance imagability, and controlled and targeted drug delivery.
Nguyen DH; Lee JS; Choi JH; Park KM; Lee Y; Park KD
Acta Biomater; 2016 Apr; 35():109-17. PubMed ID: 26884278
[TBL] [Abstract][Full Text] [Related]
6. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
[TBL] [Abstract][Full Text] [Related]
7. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
8. New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications.
Balas M; Predoi D; Burtea C; Dinischiotu A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834718
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging with theranostic nanoparticles.
Jokerst JV; Gambhir SS
Acc Chem Res; 2011 Oct; 44(10):1050-60. PubMed ID: 21919457
[TBL] [Abstract][Full Text] [Related]
10. Polydopamine-mediated bio-inspired synthesis of copper sulfide nanoparticles for T
Xiong Y; Sun F; Zhang Y; Yang Z; Liu P; Zou Y; Yu Y; Tong F; Yi C; Yang S; Xu Z
Colloids Surf B Biointerfaces; 2019 Jan; 173():607-615. PubMed ID: 30359959
[TBL] [Abstract][Full Text] [Related]
11. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.
Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F
Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321
[TBL] [Abstract][Full Text] [Related]
12. Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment.
Marshall SK; Angsantikul P; Pang Z; Nasongkla N; Hussen RSD; Thamphiwatana SD
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235009
[TBL] [Abstract][Full Text] [Related]
13. Development of Multifunctional Polydopamine Nanoparticles As a Theranostic Nanoplatform against Cancer Cells.
Wang J; Guo Y; Hu J; Li W; Kang Y; Cao Y; Liu H
Langmuir; 2018 Aug; 34(32):9516-9524. PubMed ID: 30039972
[TBL] [Abstract][Full Text] [Related]
14. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
Yang X; Shi X; Ji J; Zhai G
Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
[TBL] [Abstract][Full Text] [Related]
15. Polysaccharide-based nanoparticles for theranostic nanomedicine.
Swierczewska M; Han HS; Kim K; Park JH; Lee S
Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):70-84. PubMed ID: 26639578
[TBL] [Abstract][Full Text] [Related]
16. Effects of multiple injections on the efficacy and cytotoxicity of folate-targeted magnetite nanoparticles as theranostic agents for MRI detection and magnetic hyperthermia therapy of tumor cells.
Soleymani M; Khalighfard S; Khodayari S; Khodayari H; Kalhori MR; Hadjighassem MR; Shaterabadi Z; Alizadeh AM
Sci Rep; 2020 Feb; 10(1):1695. PubMed ID: 32015364
[TBL] [Abstract][Full Text] [Related]
17. Copper Manganese Sulfide Nanoplates: A New Two-Dimensional Theranostic Nanoplatform for MRI/MSOT Dual-Modal Imaging-Guided Photothermal Therapy in the Second Near-Infrared Window.
Ke K; Yang W; Xie X; Liu R; Wang LL; Lin WW; Huang G; Lu CH; Yang HH
Theranostics; 2017; 7(19):4763-4776. PubMed ID: 29187902
[TBL] [Abstract][Full Text] [Related]
18.
Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A
J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616
[No Abstract] [Full Text] [Related]
19. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
Cai Y; Chen X; Si J; Mou X; Dong X
Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
[TBL] [Abstract][Full Text] [Related]
20. Folate-receptor-targeted laser-activable poly(lactide-
Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]